RePORT International Resources

The San Diego (SD) Implementation Science Hub was established in 2020 with funding from the National Institutes of Health to accelerate Ending the HIV Epidemic (EHE) Initiative research. The  SD Implementation Science Hub provides consultation and technical assistance to EHE project teams from across the United States and coordinates and collaborates with the NIH-funded Capacity-building Hubs to Enhance the Science of HIV Implementation REsearch (CHESHIRE) network.

SANTHE supports innovative research projects, trainee fellowships, collaborations, leadership development, community and public engagement, and diversity and inclusion in science.

Scribbr is powered by Turnitin, a leader in plagiarism prevention

Access the SEATRAC Advanced TB Training recordings for 2023 and 2024 through this link.This virtual program offered by the University of Washington's SEATRAC, which provides advanced, multidisciplinary training in TB research. It covers key domains such as immunology and vaccines, pathogenesis and treatment, diagnostics, transmission, disease modeling, implementation science, and advocacy, geared toward both emerging and experienced investigators engaging in TB research.

These are recorded presentations from University of Washington faculty and subject matter experts for Advanced TB courses.

The Southeastern National Tuberculosis Center (SNTC) archived webinar library features recorded sessions covering diagnostics, treatment, prevention, and comorbidities, aimed at expanding individuals' knowledge and skills in tuberculosis care.

CONFERENCE DATE: 23-26 June, 2026; LOCATION: Phoenix, AZ, USA SER’s Annual Meeting brings together epidemiologists from around the world for a dynamic four-day experience of learning, connection, and celebration. Please refer to the website for the details.

This playlist includes readings on key concepts of implementation science for developing implementation research questions for individual manuscripts, study protocols, or grant applications.

The SAMRC’s vision is to build a healthy nation through research and innovation. For this vision to be realised, health researchers (locally and internationally) need funding to access the necessary resources and facilities. While the SAMRC funds many internal and external research projects itself, as well as in collaboration with partnering institutions, it also connects innovative researchers with like-minded organisations across the world that provide funding opportunities.

The Southeastern National Tuberculosis Center (SNTC) offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.

Video in multiple languages for collecting sputum sample

This questionnaire was designed for symptom measurement for persons with COPD and asthma. However, it is commonly used for persons with pulmonary TB in both clincal and reseatch settings.

Watch webinars, event recordings, and advocacy videos from the Stop TB Partnership.

A session from the 78th World Health Assembly focused on new financing models and emerging technologies in TB. Speakers emphasized sustainable investment and digital health tools to improve prevention, diagnosis, and treatment.

This session called for increased domestic TB funding in Africa, private sector engagement, and innovation in service delivery, governance, and regulation—underscoring community-driven and politically aligned strategies.

Several training packages.

This three-part webinar series by the Stop TB Partnership and FIND provides an in-depth overview of targeted next-generation sequencing (tNGS) technology for detecting drug-resistant tuberculosis. The series covers fundamental principles of tNGS, its advantages over traditional diagnostic methods, and practical guidance on implementing tNGS in high-burden and resource-limited settings. Featuring expert insights and case studies, the webinars highlight early program experiences and discuss how tNGS supports WHO-endorsed strategies to improve rapid and comprehensive detection of TB drug resistance worldwide.

This website features TAG’s latest updates in the fight to end HIV/AIDS, Hepatitis C, and Tuberculosis. It includes the Pipeline Report on innovations in diagnosing, preventing, treating, and curing HIV, HCV, and TB; information on TB research funding; recorded webinars; advocacy letters and comments submitted or endorsed by TAG; and official press releases and statements.

Please refer to the link for the TAG's latest edition of TB Treatment Pipeline Report. The report provides the latest information on 22 new or repurposed drugs in clinical development for TB and summarizes ongoing, planned, and recently completed trials. Included in this year's report are: Results from the phase 3 endTB-Q trial and two phase 2b/c trials of quabodepistat-containing regimens completed or discontinued in 2024; First-of-their-kind trials focused on asymptomatic TB and bedaquiline-resistant TB; The first long-acting formulation of a TB drug to enter clinical development; and The first phase 3 trial of a new drug from a new class since bedaquiline and delamanid.

The new 2025 update of An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis lays out what community advocates need to know about WHO-recommended regimens for drug-resistant TB. The Activist Guide reviews the evidence-base behind these regimens, important considerations for key populations affected by TB, the access landscape, and more. The publication is intended to equip advocates with information they need to formulate arguments and push for universal implementation of the best available treatments.